Partners Rx (PRx) set out to change the buying patterns that were deeply anchored in the pharmacy benefit management (PBM) industry.

Discounts and fees represent only about 5% of the drug expenditure. What should matter to you, the plan sponsor, is the average cost of a therapeutic category and what drugs are actually being utilized. By focusing on drug mix and costs by therapeutic class, we have successfully maintained the lowest drug cost trends in the industry.

Partners Rx operates in a full disclosure and open book management environment to ensure that we align our goals and objectives with those of our clients. This openness with our clients has fostered the atmosphere of trust we enjoy today.

Our partnership strategy reduces the complexity of prescription benefit management. It encourages the exchange of ideas to solve problems together.  We see value in competitive pricing strategies and rebates on appropriate medications, but at PRx, we focus on drug mix, the greatest slice of the drug cost pie by far at 95%. The question we ask ourselves everyday is how can we manage the drug mix better to further our clients' goal of achieving the Lowest Total Cost? Partners Rx has demonstrated that its strategy has proven to be successful delivering trends below industry averages in total pharmacy spend.